SNCA and Parkinson disease: The study indicated that the gut microbiome regulates neuroinflammation and α-synuclein aggregation via a pathway that affects the nervous system, modulating neuroinflammation in PD models and uncovering the crucial relationship between the gut microbiome and the neuroinflammation pathology of Parkinson’s disease.